Published in
Elsevier, Pharmacological Research, (178), p. 106162, 2022
DOI: 10.1016/j.phrs.2022.106162
Links
Tools
Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor–resistant cancer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 